NPI: 1295830172 · CHATTANOOGA, TN 37408 · Methadone Clinic · NPI assigned 09/14/2006
Authorized official FARLEY, BRIAN controls 20+ related entities in our dataset. Read more
| Authorized Official | FARLEY, BRIAN (VP & SECRETARY) |
| Parent Organization | ACADIA HEALTHCARE COMPANY, INC. |
| NPI Enumeration Date | 09/14/2006 |
Other providers sharing the same authorized official: FARLEY, BRIAN
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 39,321 | $806K |
| 2021 | 60,713 | $1.78M |
| 2022 | 70,486 | $1.93M |
| 2023 | 67,379 | $1.88M |
| 2024 | 58,308 | $1.54M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 72,276 | 15,625 | $7.88M |
| G2068 | Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) | 566 | 64 | $22K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 8,340 | 2,366 | $12K |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 173 | 104 | $6K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 46,900 | 15,756 | $1K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) | 1,523 | 395 | $339.00 |
| H0003 | Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs | 35,923 | 15,200 | $125.00 |
| G2079 | Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 30,470 | 8,963 | $32.51 |
| S0109 | Methadone, oral, 5 mg | 71,463 | 15,611 | $0.00 |
| G2076 | Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a standardized, evidence-based assessment, and that includes the patient's goals and mutually agreed-upon actions for the patient to meet those goals, including harm reduction interventions; the patient's needs and goals in the areas of education, vocational training, and employment; and the medical and psychiatric, psychosocial, economic, legal, housing, physical activity and/or nutrition needs and other recovery support services that a patient needs and wishes to pursue, conducted by an appropriately licensed/credentialed personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code | 12 | 12 | $0.00 |
| G2080 | Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 28,561 | 10,699 | $0.00 |